Our Translation platforms support the development of novel antimicrobials & diagnostics. Effective R&D including studies to determine critical function and laboratory validation support industry through TRL 3 and TRL 4, proving the early-stage performance results required to take products forward. Specialist support is available to progress novel therapeutics from hits to leads. Highly innovative technologies including nanotherapeutics, innovative humanised tissue & microfluidic models, including organoid systems & Organ-on-a-Chip is accessible to industry to fast-track drug discovery. New drug development models are also being developed to support the industry effort to combat multi-drug-resistant superbugs.